Anamika Prasad

A Drug Used to Cure Poisoning can Also Cure Deafness in Children Undergoing Chemotherapy, finds a New Trial

A trial has led to the conclusion that a medicine which is commonly used for the treatment of poisoning issues can also be extremely effective for reducing deafness in children who are undergoing chemotherapy for cancer. A paediatric oncologist at the University of Melbourne and Royal Children’s Hospital, Professor Michael Sullivan, has said that this trial focused on cisplatin, which is used for treating cancer in children, a potent chemotherapy.

These New Supercapacitors May Give Stiff Competition to Lithium Batteries

A supercapacitor with the highest energy density any other has been developed buy a theme of molecular Foundry users and stuff. The teams new design approach is such that these supercapacitor can be charged and discharged repeatedly. Much better than any other earlier version, these super capacitors as very stable and performance much better, it has a operating voltage window which is 3 times larger than the existing ones. The

Scientists Create Newer Smaller Chips for Miniature Drones

When it comes to chips powering electronic devices, their sizes are getting smaller and their effect more powerful. In line with this trend, researchers at MIT have now come up with a more evolved version of the tiny computer chip they created specifically for honey-sized drones last year. The latest chip is even tinier when it comes to size. Another plus point: it consumes less power. The Chip has been

Now an App for Deaf Parents to Determine a Reason For Baby Cry

For parents who are deaf, it is very difficult to know when their baby is crying and need their attention. Delbert Whetter, a deaf father has helped test a new app called ChatterBaby, which is helpful for cases where parents are deaf. They have been rely on cameras and remote monitoring of noise if they are in one room and they baby in another. However, this technology is not efficient.

First Human Cancer Virus Studied in Key Research at Institute for Molecular Virology

A vital discovery has been made by researchers from the University of Minnesota that is expected to hold significance in the development of a strategy to arrest the spread of human T-cell leukemia virus type 1 (HTLV-1). This highly infectious virus carries infection rates of more than 40% among central Australia adults. It is said to cause lymphoma and leukemia. Virus production is required for cell to cell spread of